文献速递泌尿生殖技术与安全MR

人工智能用于前列腺MRI自动检测癌症:机遇与持续挑战——AJR人工智能应用专题系列

Artificial Intelligence for Automated Cancer Detection on Prostate MRI: Opportunities and Ongoing Challenges, From the AJR Special Series on AI Applications.
PubMed 文献 · AJR Am J Roentgenol · 2021-12-08

前列腺MRI使用在过去十年大幅增加,主要用于引导靶向前列腺活检,但阅片者间变异仍大,人工智能有潜力标准化MRI上可疑前列腺癌病灶的检测。本综述探讨AI用于MRI自动检测前列腺癌的现状,重点介绍有前景的AI模型结果,同时描述现有文献的诸多局限,包括模型验证偏倚、性能指标报告异质性及缺乏足够的临床转化证据,并讨论AI伦理与数据治理挑战及未来研究方向。

要点

  • AI有潜力标准化前列腺MRI上可疑前列腺癌病灶的检测,减少阅片者间变异。
  • 现有AI文献存在模型验证偏倚、性能指标报告异质性及临床转化证据不足等局限。
  • 未来需大规模多样化多机构训练与测试数据集,并最终需前瞻性临床试验确立AI在患者管理中的获益。

核心结论

  • AI在前列腺MRI病灶检测中显示出有前景的结果,但现有文献存在模型验证偏倚、性能指标报告异质性及缺乏足够临床转化证据等局限,未来需大规模多样化多机构数据集开发更稳健模型,并最终需前瞻性临床试验确立获益。

研究设计与样本

  • 综述,检索并汇总近期关于AI模型用于MRI检测前列腺癌的文献,未报告具体检索范围、纳入文献数量或证据分级。

局限性

  • 现有文献存在模型验证偏倚。
  • 性能指标报告存在异质性。
  • 缺乏足够的临床转化证据。
  • 未来需大规模多样化多机构训练和测试数据集,并最终需前瞻性临床试验确立AI在患者管理中的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Use of prostate MRI has increased greatly in the past decade, primarily in directing targeted prostate biopsy. However, prostate MRI interpretation remains prone to interreader variation. Artificial intelligence (AI) has the potential to standardize detection of lesions on MRI that are suspicious for prostate cancer (PCa). The purpose of this review is to explore the current status of AI for the automated detection of PCa on MRI. Recent literature describing promising results regarding AI models for PCa detection on MRI is highlighted. Numerous limitations of the existing literature are also described, including biases in model validation, heterogeneity in reporting of performance metrics, and lack of sufficient evidence of clinical translation. Challenges related to AI ethics and data governance are also discussed. An outlook is provided for AI in lesion detection on prostate MRI in the coming years, emphasizing current research needs. Future investigations, incorporating large-scale diverse multiinstitutional training and testing datasets, are anticipated to enable the development of more robust AI models for PCa detection on MRI, though prospective clinical trials will ultimately be required to establish benefit of AI in patient management.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Turkbey, Haider. Artificial Intelligence for Automated Cancer Detection on Prostate MRI: Opportunities and Ongoing Challenges, From the AJR Special Series on AI Applications. AJR Am J Roentgenol. 2021. PMID: 34877870. doi:10.2214/AJR.21.26917

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。